Alzheimer's Biomarker Tests Development

Regulatory developments were noted for blood-based biomarker tests to detect Alzheimer's disease. These tests represent an emerging tool for early diagnosis. The update was part of a health innovation brief.

Japanese researchers identify biological cause of long COVID brain fog

08 ottobre 2025 Riportato dall'IA

Scientists in Japan have discovered a key molecular change behind the brain fog experienced by many long COVID patients. Using advanced brain imaging, they found increased density of AMPA receptors linked to cognitive impairment. The findings, published on October 1, 2025, could lead to new diagnostics and treatments.

Study associates hearing aids with lower dementia risk

A large-scale study using UK Biobank data has found that adults with hearing loss who regularly use hearing aids face a significantly reduced risk of developing dementia. The research, published in The Lancet Healthy Longevity, highlights hearing loss treatment as a potential modifiable factor in dementia prevention. This comes amid growing evidence linking untreated hearing impairment to cognitive decline.

Spotlight on tardive dyskinesia and its management

02 ottobre 2025 Riportato dall'IA

Tardive dyskinesia remains a significant side effect for patients on long-term antipsychotic medications. Recent medical discussions highlight its symptoms, causes, and emerging treatments. Awareness efforts aim to improve early detection and intervention.